Ушбу иш иқтибос қилган ишлар

47 та иш

Иш: Repurposing of Rutan showed effective treatment for COVID-19 disease

Coronavirus biology and replication: implications for SARS-CoV-2
Philip V’kovski, Annika Kratzel, Silvio Steiner +2
Шарҳ мақола20206 иқтибос
ABI
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Sandra López‐León, Talía Wegman-Ostrosky, Carol Perelman +4
Шарҳ мақола20215 иқтибос
ABI
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin, Xiaoyu Du, Yechun Xu +28
Мақола20205 иқтибос
ABI
COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
Raghuvir Keni, Anila Alexander, Pawan G. Nayak +2
Шарҳ мақола20204 иқтибос
ABI
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas +1
Мақола20204 иқтибос
ABI
Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols
Miha Bahun, Marko Jukič, Domen Oblak +7
Мақола20214 иқтибос
ABI
Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects
Min Li, Aixin Shi, Hongxian Pang +10
Мақола20143 иқтибос
ABI
C-reactive protein and the acute phase response
Mark B. Pepys
Мақола19823 иқтибос
ABI
Virus-encoded proteinases and proteolytic processing in the Nidovirales
John Ziebuhr, Alexander E. Gorbalenya, Eric J. Snijder
Шарҳ мақола20003 иқтибос
ABI
Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
Haitao Yang, Weiqing Xie, Xiaoyu Xue +16
Мақола20053 иқтибос
ABI
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
K. F Schulz, D. G Altman, D. Moher +1
Мақола20103 иқтибос
ABI
STRUCTURE OF POLYPHENOLS OF LEAVES TANNING SUMAC RHUS CORIARIA L.
Zhamollitdin Fazlitdinovich Ziyavitdinov, Yuliya Igorevna Oshchepkova, N. G. Abdulladzhanova +1
Мақола20203 иқтибос
ABI
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Jonathan Grein, Norio Ohmagari, Daniel D. Shin +53
Мақола20203 иқтибос
ABI
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
Wanchao Yin, Chunyou Mao, Xiaodong Luan +19
Мақола20203 иқтибос
ABI
Plasma CRP level is positively associated with the severity of COVID-19
Wei Chen, Kenneth I. Zheng, Saiduo Liu +3
Мақола20203 иқтибос
ABI
A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?
Victoria Pilkington, Toby Pepperrell, Andrew Hill
Шарҳ мақола20203 иқтибос
ABI
Clinical characteristics of children with COVID-19: a rapid review and meta-analysis
on behalf of COVID-19 Evidence and Recommendations Working Group, Zijun Wang, Qi Zhou +16
Шарҳ мақола20203 иқтибос
ABI
Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server
Chi Xu, Zunhui Ke, Chuandong Liu +15
Мақола20203 иқтибос
ABI
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
Zarir Udwadia, Pawan Singh, Hanmant Barkate +7
Мақола20203 иқтибос
ABI
Repurposing drugs for the management of COVID-19
Jacopo Cusinato, Ylenia Cau, Anna Maria Calvani +1
Шарҳ мақола20203 иқтибос
ABI
Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: anin silicoperspective
Oludare M. Ogunyemi, Gideon Ampoma Gyebi, Abdo A. Elfiky +4
Мақола20203 иқтибос
ABI
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Jia-Tsrong Jan, Ting-Jen Rachel Cheng, Yu-Pu Juang +14
Мақола20213 иқтибос
ABI
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
Hongbo Liu, Fei Ye, Qi Sun +7
Мақола20213 иқтибос
ABI
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential
Bjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt +16
Мақола20213 иқтибос
ABI
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner +9
Мақола20223 иқтибос
ABI

Ушбу иш иқтибос қилган ишлар

Coronavirus biology and replication: implications for SARS-CoV-2

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

COVID-19: Emergence, Spread, Possible Treatments, and Global Burden

Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an <i>in silico</i> docking and molecular dynamics simulation study

Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols

Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects

C-reactive protein and the acute phase response

Virus-encoded proteinases and proteolytic processing in the Nidovirales

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

STRUCTURE OF POLYPHENOLS OF LEAVES TANNING SUMAC RHUS CORIARIA L.

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Plasma CRP level is positively associated with the severity of COVID-19

A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?

Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

Systemic <i>In Silico</i> Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Repurposing drugs for the management of COVID-19

Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an<i>in silico</i>perspective

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

<i>Scutellaria baicalensis</i> extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease <i>in vitro</i>

Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19